Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.
Daniel Russo(IT University of Copenhagen), Alfonso Zaccaria(University of Bologna), Daniela Damiani(University of Bologna), Giuseppe Visani(Ospedali Riuniti Marche Nord), D Benfenati(University of Bologna), Eliana Zuffa(Ospedale "Santa Maria delle Croci" di Ravenna), Mariagrazia Michieli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Renato Fanin(University of Udine), C Gallizia(University of Bologna)
PubMed
March 7, 1991
Cited by 4
Related Papers
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
|Blood|2011|460
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
|Blood|2001|319
PLS-SEM for Software Engineering Research
|ACM Computing Surveys|2021|209